RJA
ASPN icon

Raymond James & Associates’s Aspen Aerogels ASPN Stock Holding History

Raymond James & Associates’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$256K Sell
9,250
-9,467
-51% -$237K ﹤0.01% 3492
2024
Q2 		$446K Buy
+18,717
New +$439K ﹤0.01% 3142
2024
Q1 		– Sell
-52,399
Closed -$827K – 3921
2023
Q4 		$827K Buy
+52,399
New +$541K ﹤0.01% 2635

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Raymond James & Associates's ASPN Position: Q3 2024 in Review

Raymond James & Associates reduced its Aspen Aerogels (ASPN) stake by 51% in Q3 2024, selling an estimated $237K and leaving 9,250 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #3492.

Raymond James & Associates first reported a position in ASPN in Q4 2023 and has held it in 3 quarters since. The position peaked at $827K in Q4 2023. 243 funds tracked by Wall St. Rank hold ASPN as of Q3 2024.

  • Raymond James & Associates held 9,250 shares of Aspen Aerogels worth $256K as of Q3 2024.
  • Raymond James & Associates sold 9,467 Aspen Aerogels shares in Q3 2024, an estimated $237K.
  • Aspen Aerogels made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3492 holding.
  • Raymond James & Associates first reported a position in Aspen Aerogels in Q4 2023 and has held it in 3 quarters since.
  • Raymond James & Associates's Aspen Aerogels position peaked at $827K in Q4 2023.
  • 243 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.